US loss of exclusivity · Oncology
Kisqali
Novartis
2031
US generics from
2025
Today: 2026
2037
2025 worldwide sales
$4.8B
Date basis
Company guidance
US generics
No US filing found
Medicare price
Pending, from 2028
Pharma Patent Cliff
by readouts.io
Data checked 24 October 2026 ·
Full Kisqali timeline →